ESTRO Brachytherapy for Prostate Cancer 2018

Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes. Stone NN , Potters L , Davis BJ , Ciezki JP , Zelefsky MJ , Roach M , Fearn PA , Kattan MW , Stock RG

6 centers – 3928 PB patients with post-implant dosimetry results Stratification in low- (2188), intermediate (n=1188) and high (n=522) risk groups

AND

Into 3 BED groups: – < 140 Gy (n = 524) – 140-200 Gy (n = 2284) – >200 Gy (n = 1115)

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1472-7